MRNANasdaq · Biological Products, (No Diagnostic Substances)

Moderna, Inc.

Alert me on MRNA

Insider buys, 6 months

Congress trades, 6 months

Signals, 6 months

Six months

After each filing

Oct 17 Sale Hoge Stephen Insider

1 week

Result in1 trading day

1 month

Result in17 trading days

3 months

Result in59 trading days

6 months

Result in122 trading days

Oct 7 Sale Rep. Maria Elvira Salazar House

1 week

+20.1%S&P −0.3%

1 month

Result in10 trading days

3 months

Result in52 trading days

6 months

Result in115 trading days

Sep 17 Sale Hoge Stephen Insider

1 week

+23.2%S&P +0.9%

1 month

+37.9%S&P +0.3%

3 months

Result in37 trading days

6 months

Result in100 trading days

Sep 15 Sale Mock James M Insider

1 week

+27.0%S&P +2.4%

1 month

+57.4%S&P +1.9%

3 months

Result in35 trading days

6 months

Result in98 trading days

Sep 9 Buy Rep. Maria Elvira Salazar House

1 week

+15.7%S&P +0.6%

1 month

+64.7%S&P +3.0%

3 months

Result in32 trading days

6 months

Result in95 trading days

Show all 21

Sep 9 Sale Rep. Maria Elvira Salazar House

1 week

+15.7%S&P +0.6%

1 month

+64.7%S&P +3.0%

3 months

Result in32 trading days

6 months

Result in95 trading days

Sep 4 Sale Klinger Shannon Thyme Insider

1 week

+0.8%S&P −1.2%

1 month

+28.8%S&P +1.4%

3 months

Result in29 trading days

6 months

Result in92 trading days

Aug 8 Sale Bancel Stephane Insider

1 week

+7.8%S&P 0.0%

1 month

+126.7%S&P −1.4%

3 months

Result in10 trading days

6 months

Result in73 trading days

Jul 17 Sale Hoge Stephen Insider

1 week

−12.5%S&P −0.6%

1 month

+4.3%S&P +4.0%

3 months

+282.6%S&P +4.1%

6 months

Result in57 trading days

Jun 18 Sale Hoge Stephen Insider

1 week

+5.2%S&P −2.4%

1 month

−6.7%S&P +0.2%

3 months

+140.8%S&P +2.3%

6 months

Result in38 trading days

Jun 9 Sale Klinger Shannon Thyme Insider

1 week

+16.1%S&P +1.8%

1 month

+43.0%S&P +2.7%

3 months

+184.1%S&P +3.7%

6 months

Result in31 trading days

May 23 Sale AFEYAN NOUBAR Insider

1 week

−3.0%S&P +1.2%

1 month

+27.0%S&P −1.9%

3 months

+237.7%S&P +2.3%

6 months

Result in21 trading days

May 19 Sale Hoge Stephen Insider

1 week

+4.1%S&P +2.3%

1 month

+39.9%S&P +2.0%

3 months

+281.4%S&P +5.1%

6 months

Result in17 trading days

May 5 Sale Hussain Abbas Insider

1 week

+14.0%S&P +2.0%

1 month

+10.4%S&P +4.6%

3 months

+20.4%S&P +6.6%

6 months

Result in7 trading days

Mar 4 Sale Klinger Shannon Thyme Insider

1 week

−3.2%S&P −1.3%

1 month

−14.9%S&P −4.0%

3 months

−15.1%S&P +10.4%

6 months

+160.9%S&P +12.3%

Feb 26 Sale Hoge Stephen Insider

1 week

+4.1%S&P −1.2%

1 month

−4.2%S&P −7.8%

3 months

−8.0%S&P +9.8%

6 months

+176.1%S&P +12.5%

Dec 15, 2025 Sale AFEYAN NOUBAR Insider

1 week

+16.6%S&P +0.9%

1 month

+31.6%S&P +2.0%

3 months

+75.1%S&P −2.6%

6 months

+106.6%S&P +9.5%

Dec 12, 2025 Sale Hussain Abbas Insider

1 week

+14.7%S&P +0.1%

1 month

+37.7%S&P +1.6%

3 months

+83.1%S&P −1.3%

6 months

+88.1%S&P +10.7%

May 8, 2025 Sale Rep. Rob Bresnahan House

1 week

+2.5%S&P +5.3%

1 month

+14.1%S&P +6.9%

3 months

+5.0%S&P +13.0%

6 months

+1.2%S&P +19.6%

Mar 27, 2025 Buy Rep. Rob Bresnahan House

1 week

−19.3%S&P −9.1%

1 month

−10.6%S&P −0.2%

3 months

−11.3%S&P +11.5%

6 months

−18.6%S&P +20.1%

Feb 12, 2025 Sale Rep. Julie Johnson House

1 week

+11.3%S&P −1.6%

1 month

+8.7%S&P −7.0%

3 months

−25.9%S&P −2.9%

6 months

−12.2%S&P +6.2%

Every purchase and sale on this ticker reported by a member of Congress or an insider, measured from the close of the first trading day after it became public to the close 1 week, 1 month, 3 months and 6 months later, each beside the S&P over the same days.

Filings for MRNA

101 held · newest 5101 held · newest 2

Loading the filings.

See all 101 filings for MRNA

Aeon news and offers by email

New sources, new features and offers like our founding price. A few times a month at most. Stop any time.

Signal history

No signal for this ticker yet. A signal is written when insider buying here scores one dot or more.

Stakes

Jun 30, 2026 Schedule 13G

Capital World Investors: 5.6%, 22,276,996 shares

Jun 30, 2026 Schedule 13G, amended

FMR LLC: 13.1%, 51,803,891 shares

Jun 30, 2026 Schedule 13G, amended

BAILLIE GIFFORD & CO: 4.6%, 18,206,778 shares

Mar 31, 2026 Schedule 13G

Vanguard Capital Management: 6.5%, 25,933,824 shares

Mar 13, 2026 Schedule 13G, amended

The Vanguard Group: 0%, 0 shares

Dec 31, 2025 Schedule 13G, amended

BAILLIE GIFFORD & CO: 5.3%, 20,580,514 shares

Jan 30, 2026 Schedule 13G, amended

FMR LLC: 10.6%, 41,301,469 shares

Dec 31, 2025 Schedule 13G

FMR LLC: 7.2%, 27,961,311 shares

Sep 30, 2025 Schedule 13G, amended

FMR LLC: 3.2%, 12,304,297 shares

Schedule 13D is filed within 5 business days of crossing 5 percent by an investor who may seek to influence the company. Schedule 13G is filed by a passive holder, and a large institution has up to 45 days after the quarter end.

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal

No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters

$130KQ4 2025

$190KQ1 2026

$290KQ2 2026

$70KQ3 2026

Down 76 percent from Q2 2026. Reported by the company to the Senate each quarter.Original report ↗

Read from LDA.gov between Sep 23, 2026 and Oct 21, 2026. Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.